Brief: Australian Clinical Labs Says HY Total Revenue From Ordinary Activities Down 33.03% To A$360.3M

Australian Clinical Labs

20/02/2023 01:16

Feb 20 (Reuters) - Australian Clinical Labs Ltd
 ACL.AX :
    * HY TOTAL REVENUE FROM ORDINARY ACTIVITIES DOWN 33.03% TO
A$360.3M
    * HY PROFIT ATTRIBUTABLE DOWN 80.48% TO A$25.4M
    * DECLARED INTERIM DIVIDEND OF 7.00 AU CENTS PER SHARE

Source text for Eikon:  ID:nASX682xz 
Further company coverage:  ACL.AX